Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.750
+0.120 (4.56%)
May 9, 2025, 10:21 AM - Market open

Cardiff Oncology Statistics

Total Valuation

CRDF has a market cap or net worth of $182.94 million. The enterprise value is $96.43 million.

Market Cap 182.94M
Enterprise Value 96.43M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

CRDF has 66.52 million shares outstanding. The number of shares has increased by 18.88% in one year.

Current Share Class 66.52M
Shares Outstanding 66.52M
Shares Change (YoY) +18.88%
Shares Change (QoQ) +22.70%
Owned by Insiders (%) 2.01%
Owned by Institutions (%) 36.20%
Float 59.80M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 237.97
Forward PS 454.66
PB Ratio 2.47
P/TBV Ratio 2.47
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 164.27
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.22, with a Debt / Equity ratio of 0.02.

Current Ratio 6.22
Quick Ratio 6.04
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -74.15% and return on invested capital (ROIC) is -48.20%.

Return on Equity (ROE) -74.15%
Return on Assets (ROA) -41.00%
Return on Invested Capital (ROIC) -48.20%
Return on Capital Employed (ROCE) -72.85%
Revenue Per Employee $17,788
Profits Per Employee -$1.48M
Employee Count 33
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.54% in the last 52 weeks. The beta is 1.80, so CRDF's price volatility has been higher than the market average.

Beta (5Y) 1.80
52-Week Price Change -20.54%
50-Day Moving Average 3.25
200-Day Moving Average 3.14
Relative Strength Index (RSI) 41.22
Average Volume (20 Days) 1,143,762

Short Selling Information

The latest short interest is 17.34 million, so 26.06% of the outstanding shares have been sold short.

Short Interest 17.34M
Short Previous Month 14.81M
Short % of Shares Out 26.06%
Short % of Float 28.99%
Short Ratio (days to cover) 11.79

Income Statement

In the last 12 months, CRDF had revenue of $587,000 and -$48.88 million in losses. Loss per share was -$0.92.

Revenue 587,000
Gross Profit -36.27M
Operating Income -52.10M
Pretax Income -40.86M
Net Income -48.88M
EBITDA -51.71M
EBIT -52.10M
Loss Per Share -$0.92
Full Income Statement

Balance Sheet

The company has $79.89 million in cash and $1.36 million in debt, giving a net cash position of $78.53 million or $1.18 per share.

Cash & Cash Equivalents 79.89M
Total Debt 1.36M
Net Cash 78.53M
Net Cash Per Share $1.18
Equity (Book Value) 70.88M
Book Value Per Share 1.07
Working Capital 69.42M
Full Balance Sheet

Cash Flow

Operating Cash Flow -42.75M
Capital Expenditures n/a
Free Cash Flow -42.75M
FCF Per Share -$0.64
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -8,875.64%
Pretax Margin -8,322.66%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRDF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -18.88%
Shareholder Yield -18.88%
Earnings Yield -27.94%
FCF Yield -24.43%

Analyst Forecast

The average price target for CRDF is $12.25, which is 345.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.25
Price Target Difference 345.46%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 168.02%
EPS Growth Forecast (5Y) 16.48%
Stock Forecasts

Stock Splits

The last stock split was on February 20, 2019. It was a reverse split with a ratio of 0.1666666:1.

Last Split Date Feb 20, 2019
Split Type Reverse
Split Ratio 0.1666666:1

Scores

Altman Z-Score n/a
Piotroski F-Score 3